Last updated: 4 months ago
EDAP TMS S.A. Reports Record Q4 2024 Sales & U.S. Market Growth Insights
Discover EDAP TMS S.A.'s impressive Q4 2024 preliminary results, featuring record Focal One sales and a 30% growth in U.S. prostate cancer procedures. Learn about future expectations and risks.